# FDA Inspection 856342 - Wickliffe Pharmaceutical Inc - December 03, 2013

Source: https://www.keypedia.com/records/fda_inspections/wickliffe-pharmaceutical-inc/de39115e-1423-4b1b-b579-2d29c4bbf92e
Source feed: FDA_Inspections

> FDA Inspection 856342 for Wickliffe Pharmaceutical Inc on December 03, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 856342
- Company Name: Wickliffe Pharmaceutical Inc
- Inspection Date: 2013-12-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1218721 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/wickliffe-pharmaceutical-inc/4fd6385a-bab5-4e0f-ab65-f73c261f5043)
- [FDA Inspection 971802 - 2016-04-07](https://www.keypedia.com/records/fda_inspections/wickliffe-pharmaceutical-inc/e0136899-2df8-4987-b09f-82276bb2b42a)
- [FDA Inspection 880722 - 2014-05-22](https://www.keypedia.com/records/fda_inspections/wickliffe-pharmaceutical-inc/73065992-a376-4e87-8a12-06ca3dad3b33)

Company: https://www.keypedia.com/companies/wickliffe-pharmaceutical-inc/86fc3eb8-322a-47f6-8828-f8ccfe8a1f53

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c